A detailed history of Motley Fool Asset Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 16,370 shares of VTRS stock, worth $183,344. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,370
Previous 17,790 7.98%
Holding current value
$183,344
Previous $189,000 0.53%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $14,654 - $17,224
-1,420 Reduced 7.98%
16,370 $190,000
Q2 2024

Aug 08, 2024

SELL
$10.05 - $12.02 $7,014 - $8,389
-698 Reduced 3.78%
17,790 $189,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $625,079 - $750,427
-55,464 Reduced 75.0%
18,488 $220,000
Q1 2024

May 08, 2024

BUY
$11.27 - $13.53 $614,327 - $737,520
54,510 Added 280.37%
73,952 $882,000
Q4 2023

Feb 02, 2024

SELL
$8.77 - $10.85 $18,250 - $22,578
-2,081 Reduced 9.67%
19,442 $210,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $4,603 - $5,448
-480 Reduced 2.18%
21,523 $212,000
Q2 2023

Aug 09, 2023

SELL
$9.02 - $10.29 $15,640 - $17,842
-1,734 Reduced 7.31%
22,003 $219,000
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $13,569 - $18,083
1,475 Added 6.63%
23,737 $228,000
Q4 2022

Feb 09, 2023

SELL
$8.72 - $11.56 $13,821 - $18,322
-1,585 Reduced 6.65%
22,262 $247,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $4,748 - $6,232
-560 Reduced 2.29%
23,847 $203,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $726 - $895
-73 Reduced 0.3%
24,407 $256,000
Q1 2022

May 04, 2022

BUY
$9.81 - $15.4 $234,498 - $368,121
23,904 Added 4150.0%
24,480 $266,000
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $6,963 - $8,455
576 New
576 $8,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Motley Fool Asset Management LLC Portfolio

Follow Motley Fool Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.